Hirono Iriuchishima

3PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 29, 2024
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain.

Hirono Iriuchishima, Akio Saito, Masahiro Mihara

|May 11, 2019
Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.

Hirono Iriuchishima, Akito Maeshima, Shunsuke Takahashi

Pageof 1